|University of Oklahoma College of Medicine|
|City: Oklahoma City||State: OK|
The University of Oklahoma has requested a re-evaluation of their curriculum grade. Their curriculum domain increased from a 1 to a 3 and their overall score increased from a C to a B.
Summary: Most of the policies at University of Oklahoma College of Medicine begin to address the potential for conflicts of interest. The policy on purchasing and formularies is exemplary, as are the limits placed on scholarships for students and trainees. In 2011, this institution submitted additional information for the sample and curriculum domains. The sample policy submitted does not address the use of pharmaceutical and medical device sample distribution by industry representatives and their use amongst patient populations. The policy does, though, clearly list potential sanctions for non-compliance. The institution's policy on gifts and meals could be strengthened if it was clearly stated to apply to not only medical students as it does now, but to all trainees, faculty, and staff.
Demographics: The three primary sites of student training are Oklahoma University Medical Center, Oklahoma University Physician's Clinic, and the Oklahoma VA Hospital. Submitted policies apply to Oklahoma University Medical Center.
Updates: This institution submitted new policies for review for the 2011-12 AMSA PharmFree Scorecard, their grade improved to a B.
This institution's evaluation was last updated: 4/9/2013
|Gifts & Meals||This policy prohibits the acceptance of gifts from vendors including meals, but this policy only applies to medical students and not all faculty and staff.|
|Consulting relationships||The policy specifies that consultant fees “should be commensurate with the level of service provided.” Additionally, fees should not be accepted for simply attending events or for having loose connections with pharmaceutical companies.|
|Industry-funded speaking relationships||
Physicians and residents may serve as educational speakers, but must not serve as promotional speakers.
All employees required to disclose all financial interests as they arise or at least annually.
|Pharmaceutical samples||Samples may be stored in a cabinet or closet in the clinical area. This practice does not limit the use of samples as a marketing tool.|
|Purchasing & Formularies||
Exemplary policy: "Health care professionals who serve on any committees dealing with pharmacy, formulary, equipment or device selection, or clinical practice guidelines shall disclose to the respective committee membership any consulting or sponsoring relationships they have with any commercial entity during the time or their committee service and for two years after termination of the relationship. Such professionals should recuse themselves from any committee decisions which may suggest conflict from their commercial relationship(s)."
|Industry Sales Representatives||
Industry sales representatives are only allowed on-site in non-patient care areas by appointment or invitation from a physician or, in the case of medical students, by appointment or invitation from the supervising physician.
Industry cannot control speakers/content, but contributions do not need to be at institutional level.
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||
Financial assistance for off-site education is permitted, but only when attendees are selected by the AMC supervisor and the grants are unrestricted and given directly to the AMC supervising unit, not the attendee.
|Industry Support for Scholarships & Funds for Trainees||The policy prohibits industry from selecting the recipient(s) of scholarships or trainee funds.|
|Medical school curriculum||Conflict of Interest is addressed in a number of different courses, including the clinical clerkships and an Ethics course. Students receive a lecture specifically detailing what conflict of interest is and how it effects patient care.|
|Do the policies specify an oversight mechanism?||Oversight clearly stated.|
|Are there explicit sanctions for noncompliance?||
Sanctions for noncompliance are clearly referenced.
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|